Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.11 | 0.7 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |